Eli Lilly vows insulin prices won’t rise; Novo Nordisk, Sanofi hedge
An Eli Lilly & Co. logo is seen on a box of insulin medication on this arranged photograph at a ...
Tag: Eli
Eli Lilly treatment donanemab slowed disease progression
The Alzheimer's treatment donanemab, which is made by Eli Lilly, significantly slowed progression of the mind-robbing disease, in line with ...
FDA commissioner praises Eli Lilly Alzheimer’s treatment results
FDA Commissioner Dr. Robert Califf speaks at an event celebrating hearing aids being available over-the-counter at a Walgreens in Washington, ...
Eli Lilly weight reduction drug tirzepatide data released
Patients who took Eli Lilly's weight reduction drug tirzepatide lost as much as 34 kilos on average, or 16% of ...
Eli Lilly (LLY) Q1 earnings 2023
Eli Lilly's first-quarter earnings missed expectations Thursday, however the pharmaceutical company raised its full-year guidance.Before the earnings release, the corporate ...
Eli Lilly, Sanofi, Novo Nordisk testify to Senate on prices
On this photo illustration, an insulin pen manufactured by the Novo Nordisk company is displayed on March 14, 2023 in ...
Facing political pressure, Sanofi follows Eli Lilly and Novo Nordisk in slashing insulin prices
A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a pharmacy in Provo, Utah, ...
Novo Nordisk to slash U.S. insulin prices by as much as 75% after Eli Lilly
Novo Nordisk Inc. NovoLog brand insulin pens are arranged for a photograph within the Brooklyn borough of Latest York, U.S., ...
Eli Lilly treatment solanezumab didn’t slow disease
Eli Lilly on Wednesday said it should halt development of its Alzheimer's treatment candidate solanezumab after the antibody didn't slow ...
Eli Lilly recruits Black patients for Alzheimer’s trial, drugmakers seek diversity
Sharon Kimbrough went to the Black Women's Expo in Atlanta to sell her memoir. Getting tested for Alzheimer's was the ...
